The combination of the DNMT inhibitor 5-azacytidine and the HDAC inhibitor entinostat inhibited growth of K-ras/p53 mutant lung adenocarcinoma in an orthotopic lung cancer mouse model (Belinsky et al., 2011). The gene discussed is HDAC9; the disease is lung cancer.